NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NK | NantKwest Inc | Healthcare | Biotechnology | 3.90% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| AUPH | Aurinia Pharmaceuticals Inc | Healthcare | Biotechnology | 2.71% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.62% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.41% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.34% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 2.21% |
| NVAX | Novavax Inc | Healthcare | Biotechnology | 2.17% |
| DAWN | Day One Biopharmaceuticals Inc | Healthcare | Biotechnology | 2.13% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.13% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.04% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 2.01% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 1.97% |
| IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 1.95% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 1.86% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 1.85% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 1.84% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.70% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 1.69% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.66% |